Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)

China · Delayed Price · Currency is CNY

8.55

+0.18 (2.15%)

Sep 30, 2026, 3:04 PM CST

Market Cap	7.09B +20.0%
Revenue (ttm)	1.48B +5.0%
Net Income	224.77M +8.1%
EPS	0.27 +7.2%
Shares Out	828.87M
PE Ratio	31.23
Forward PE	n/a
Dividend	0.09 (1.05%)
Ex-Dividend Date	May 29, 2026

Volume	62,297,657
Open	8.58
Previous Close	8.37
Day's Range	8.39 - 8.70
52-Week Range	5.99 - 9.26
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About SHE:002349

Jinghua Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers active pharmaceutical ingredients (APIs) and intermediates, chemical and pharmaceutical intermediates, Chinese medicinal herbs and materials, health products, and Western medicine products. It also provides Jidesheng antivenomous tablets, Nantong Wang’s baby health pill, Ningning ZhengChaihu granules, Dachaihu granules, Gubenkechuan tablets, dizzine... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1957

Employees 1,462

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002349

Full Company Profile

Financial Performance

In 2025, SHE:002349's revenue was 1.46 billion, an increase of 4.13% compared to the previous year's 1.40 billion. Earnings were 219.28 million, an increase of 3.12%.

Financial Statements